Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

41.21

+0.35

(+0.86%)

At close: 04:00PM EDT

41.90

+0.69

(+1.67%)

After hours:

07:55PM EDT

Loading interactive chart...

Zacks
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GuruFocus.com
Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
Revenue Surges by 21% Year-Over-Year, Net Income Doubles
Zacks
Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 14.49% and 2.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?